Somnigroup International Earnings Call Transcripts
Fiscal Year 2026
-
The meeting covered director elections, auditor ratification, executive compensation, and an amendment to double authorized shares. All proposals passed by majority vote, with no questions raised by stockholders.
-
Q1 2026 saw 12% sales growth and 20% adjusted EPS growth, with strong cash flow and market outperformance despite industry headwinds. 2026 guidance was reaffirmed, and the Leggett & Platt merger is expected to close by year-end, delivering significant synergies.
-
Somnigroup outlined its strategy as the world's largest bedding company, emphasizing vertical integration, omnichannel reach, and innovation. Updated 2028 targets include 24% EPS CAGR, mid-single-digit sales growth, and $225 million in synergies from the Mattress Firm acquisition. Enhanced marketing, operational efficiencies, and a disciplined capital allocation plan support long-term growth.
Fiscal Year 2025
-
Record Q4 and full-year results were achieved despite industry headwinds, with strong sales, margin expansion, and accelerated synergy realization from the Mattress Firm combination. 2026 guidance anticipates continued growth, robust cash flow, and increased shareholder returns.
-
Record Q3 results with 63% sales growth and 16% EPS increase, driven by Mattress Firm integration and strong international performance. Raised 2025 EPS guidance, accelerated synergy realization, and announced increased shareholder returns for 2026.
-
Record Q2 net sales and EBITDA driven by Mattress Firm integration and international growth. Raised 2025 EPS guidance, with synergy realization ahead of plan and strong product launches offsetting industry headwinds.
-
Q1 2025 saw $1.6B in sales and $0.49 adjusted EPS, with strong international growth and Mattress Firm integration driving synergies. 2025 guidance was revised lower due to weak U.S. demand, but margin improvements and cost actions are expected to offset tariff and commodity headwinds.
-
The acquisition of Mattress Firm has closed, forming the world's largest bedding company and prompting a rebrand to Somnigroup International. The deal accelerates vertical integration, enhances innovation, and is expected to be accretive from day one, with full synergy benefits realized over 3–4 years.
Fiscal Year 2024
-
Q4 2024 sales reached $1.2B with adjusted EPS of $0.60, outperforming expectations due to strong international growth. The company completed the Mattress Firm merger, guiding for 2025 adjusted EPS of $2.60–$3.00 and targeting $100M in annual synergies by 2028.
-
Net sales rose 2% to $1.3B and adjusted EBITDA grew 6% year-over-year, with strong international and brand performance. 2024 guidance implies 4% EPS growth, and the Mattress Firm acquisition is progressing amid industry volumes 30% below 2021 peak.
-
Q2 2024 saw $1.2B in sales, 6% adjusted EBITDA growth, and 9% higher EPS, with strong margin expansion despite industry softness. Guidance calls for flat full-year sales, 6% EPS growth, and continued share gains, supported by innovation and disciplined capital allocation.
-
FTC litigation challenges the planned combination, but management remains confident in the transaction's legal and competitive merits. Commitments to divestitures and multi-brand retailing aim to address regulatory concerns, with litigation expected to conclude by early 2025.